EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report

Mario A Hermsen; Matt Lechner; Leticia Oliveira Ferrer; Annalisa Trama; Patrick René Gerhard Eriksen; Eva Martinez-Balibrea; Christian von Buchwald

doi:10.1016/j.oraloncology.2023.106543

EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report

Mario A Hermsen^*, Matt Lechner, Leticia Oliveira Ferrer, Annalisa Trama, Patrick René Gerhard Eriksen, Eva Martinez-Balibrea, Christian von Buchwald

^*Corresponding author for this work

Department of Otorhinolaryngology, Head and Neck Surgery and Audiology

Abstract

Sinonasal cancer is a clinically and histologically heterogeneous group of rare tumors with generally poor clinical outcomes. Their low incidence hampers the advancement of clinical management as well as translational research, and calls for multicenter and multinational collaboration between physicians and researchers. This report describes the proceedings of a two-day conference organized by the European Network for Sinonasal Cancer Research (EUSICA) and COST Action 'IMMUNO-model', fostering such collaboration and focusing on preclinical tumor and immuno models, surgical and radio-oncological treatments, core facilities for genetic characterization and molecular tumor classification, and cancer registry.

Original language	English
Article number	106543
Journal	Oral Oncology
Volume	146
ISSN	1368-8375
DOIs	https://doi.org/10.1016/j.oraloncology.2023.106543
Publication status	Published - Nov 2023

Access to Document

10.1016/j.oraloncology.2023.106543

Cite this

@article{db7c92a3b4c140238624f7e21e572590,

title = "EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report",

abstract = "Sinonasal cancer is a clinically and histologically heterogeneous group of rare tumors with generally poor clinical outcomes. Their low incidence hampers the advancement of clinical management as well as translational research, and calls for multicenter and multinational collaboration between physicians and researchers. This report describes the proceedings of a two-day conference organized by the European Network for Sinonasal Cancer Research (EUSICA) and COST Action 'IMMUNO-model', fostering such collaboration and focusing on preclinical tumor and immuno models, surgical and radio-oncological treatments, core facilities for genetic characterization and molecular tumor classification, and cancer registry.",

author = "Hermsen, {Mario A} and Matt Lechner and {Oliveira Ferrer}, Leticia and Annalisa Trama and Eriksen, {Patrick Ren{\'e} Gerhard} and Eva Martinez-Balibrea and {von Buchwald}, Christian",

note = "Copyright {\textcopyright} 2023. Published by Elsevier Ltd.",

year = "2023",

month = nov,

doi = "10.1016/j.oraloncology.2023.106543",

language = "English",

volume = "146",

journal = "Oral Oncology",

issn = "1368-8375",

publisher = "Pergamon",

}

TY - JOUR

T1 - EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research

T2 - A meeting report

AU - Hermsen, Mario A

AU - Lechner, Matt

AU - Oliveira Ferrer, Leticia

AU - Trama, Annalisa

AU - Eriksen, Patrick René Gerhard

AU - Martinez-Balibrea, Eva

AU - von Buchwald, Christian

PY - 2023/11

Y1 - 2023/11

N2 - Sinonasal cancer is a clinically and histologically heterogeneous group of rare tumors with generally poor clinical outcomes. Their low incidence hampers the advancement of clinical management as well as translational research, and calls for multicenter and multinational collaboration between physicians and researchers. This report describes the proceedings of a two-day conference organized by the European Network for Sinonasal Cancer Research (EUSICA) and COST Action 'IMMUNO-model', fostering such collaboration and focusing on preclinical tumor and immuno models, surgical and radio-oncological treatments, core facilities for genetic characterization and molecular tumor classification, and cancer registry.

AB - Sinonasal cancer is a clinically and histologically heterogeneous group of rare tumors with generally poor clinical outcomes. Their low incidence hampers the advancement of clinical management as well as translational research, and calls for multicenter and multinational collaboration between physicians and researchers. This report describes the proceedings of a two-day conference organized by the European Network for Sinonasal Cancer Research (EUSICA) and COST Action 'IMMUNO-model', fostering such collaboration and focusing on preclinical tumor and immuno models, surgical and radio-oncological treatments, core facilities for genetic characterization and molecular tumor classification, and cancer registry.

UR - http://www.scopus.com/inward/record.url?scp=85167777555&partnerID=8YFLogxK

U2 - 10.1016/j.oraloncology.2023.106543

DO - 10.1016/j.oraloncology.2023.106543

M3 - Comment/debate

C2 - 37573683

SN - 1368-8375

VL - 146

JO - Oral Oncology

JF - Oral Oncology

M1 - 106543

ER -

EUSICA/COST IMMUNO-model workshop fostering collaboration to advance sinonasal cancer research: A meeting report

Abstract

Access to Document

Other files and links

Fingerprint

Cite this